The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Re… (NCT07299162) | Clinical Trial Compass
RecruitingNot Applicable
The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Receiving Rehabilitation
Turkey (Türkiye)38 participantsStarted 2025-08-15
Plain-language summary
Stroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negatively impacts patients' activities of daily living, such as eating and dressing. Various rehabilitation methods are used to improve the function of the paretic upper extremity in stroke patients. Action Observation Therapy and Virtual Reality are among the rehabilitation approaches currently used to support upper extremity rehabilitation.
In our study, patients will be randomly divided into two groups: one group will receive conventional rehabilitation and Action Observation Therapy, while the other group will additionally receive Virtual Reality therapy. This study aims to investigate the contribution of Virtual Reality therapy, when added to conventional rehabilitation and Action Observation Therapy, to the recovery of the paretic upper extremity in patients with subacute stroke.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients over the age of 18
* Patients in the subacute phase of stroke (between 6 weeks and 6 months post-stroke)
* Patients with a first-ever stroke
* Brunnstrom stage 3 or above for both upper extremity and hand
* Mini-Mental State Examination (MMSE) score \>=20
No major medical condition that would prevent participation in the treatment
Exclusion Criteria:
* Presence of pain in the paretic shoulder severe enough to prevent exercise
* History of bilateral stroke
* Patients with global aphasia and/or cognitive impairment that significantly affects treatment compliance
* Patients with severe visual impairment
* Presence of unilateral spatial neglect
* Inability to maintain sitting balance
* Modified Ashworth Scale \> 4 in the hemiplegic arm
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fugl-Meyer Upper Extremity
Timeframe: From enrollment to the 1 months after treatment
Trial details
NCT IDNCT07299162
SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital